Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(19):1401-1403; doi:10.1093/jnci/dji354
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hayasaka, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayasaka, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Approaches Vary for Clinical Trials in Developing Countries

Elana Hayasaka

The first 150 words of the full text of this article appear below.

In a hospital in Morocco, cancer patients must wait 2 or 3 days for a bed to open up. In a Guatemalan health center, two harried clinicians juggle all of the more than 400 new cases of leukemia each year. In some places in India, 60%–70% of cancer patients are turned away from hospitals because of a lack of medical resources.

"Clinical trials? Wouldn't [providing] soap be a better place to start?" Ronald Barr, M.D., of McMaster University in Canada, said of conducting clinical trials in developing countries, only half joking. He remembers handing out blocks of soap to doctors in Kenya, who gave the precious bars to parents as an incentive not to abandon their sick children in hospitals. "There are huge fundamental challenges that need to be addressed before you can think about doing trials," he added.


Figure Removed (Available Only in the Full Text)
View larger version (152K):
[in this window]
[in a new window]
  		Ronald Barr

 
Researchers at pharmaceutical companies and academic institutions and . . . [Full Text of this Article]

Problems With Designing Trials

Creating Trials that Work


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?